Rigosertib Products | Cleanchem - Rigosertib is an experimental drug being studied for the treatment of myelodysplastic syndromes (MDS) and other hematologic malignancies. It works by inhibiting specific signaling pathways that are involved in cancer cell proliferation and survival. Clinical trials are ongoing to evaluate its safety and effectiveness in treating blood cancers.